| Stage | PRCH | % of rev | MAMA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $144M | 100.00% | $55M | 100.00% | PRCH ×2.64 |
| Gross profit | $108M | 74.98% | $13M | 23.96% | PRCH +51.0pp |
| Operating income | $18M | 12.57% | $3M | 5.48% | PRCH +7.1pp |
| Pre-tax income | $8M | 5.57% | $3M | 6.05% | MAMA +0.5pp |
| Net income | $9M | 6.27% | $3M | 4.70% | PRCH +1.6pp |
| Stage | PRCH | MAMA | Gap · A − B |
|---|---|---|---|
| Revenue | $144M100.00% | $55M100.00% | PRCH ×2.64 |
| Gross profit | 74.98%$108M | 23.96%$13M | PRCH +51.0pp |
| Operating income | 12.57%$18M | 5.48%$3M | PRCH +7.1pp |
| Pre-tax income | 5.57%$8M | 6.05%$3M | MAMA +0.5pp |
| Net income |
| 6.27%$9M |
| 4.70%$3M |
| PRCH +1.6pp |
No shared counterparties.